Merger Market publishes interview with Prolight Diagnostics CEO, Ulf Bladin

The international and financial journal Merger Market has published an interview with Prolight Diagnostics CEO, Ulf Bladin where you may read e.g. how Prolight has accelerated business development by initiating contacts with potential partners.

Merger Market published the interview, which can be read in its entirety at https://prolightdx.com/en/mediaeng/articles/

For further information, please contact:
Prolight Diagnostics AB (publ)
E-mail: ub@prolightdx.com
Telephone: +46 73 582 39 87
Website: www.prolightdx.com/en/

About Us
Prolight Diagnostics AB develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.
We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of troponin, to aid in the rule-in and rule-out of myocardial infarction.
 
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.

Attachments
Merger Market publishes interview with Prolight Diagnostics CEO, Ulf Bladin
Merger Market Prolight

Merger Market publishes interview with Prolight Diagnostics CEO, Ulf Bladin
Merger Market Prolight
Back

Subscribe